Diagnostic and therapeutic significance of blood lipid spectrum in rheumatoid arthritis depending on comorbidity.

Abstract

The modern approach to the treatment of rheumatoid arthritis (RA) remains relevant, in particular, due to inadequate control of systemic inflammation, simultaneous administration of a large number of potentially dangerous drugs, which provokes the emergence of comorbid pathology, which complicates the course and treatment of this disease. The aim of the study. To establish the role of disorders of the blood lipid spectrum in the development and progression of RA against the background of abdominal obesity (AO), type 2 diabetes mellitus (T2DM), and arterial hypertension (AH).